Skip to content

Internet-Based Treatment of Depression: Comparing Guided With Unguided Self-Help

Internet-Based Treatment of Depression: A Randomized Controlled Trial Comparing Guided With Unguided Self-Help

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04428450
Enrollment
76
Registered
2020-06-11
Start date
2009-09-01
Completion date
2010-12-31
Last updated
2024-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Brief summary

The study is a randomized controlled trial and to compare the benefits of a 10-week web-based unguided self-help treatment with the same intervention complemented with weekly therapist support via e-mail. A waiting-list control group will be included. The Beck Depression Inventory (BDI-II) will be used as the primary outcome measure. Secondary outcomes include general psychopathology, interpersonal problems, and quality of life.

Detailed description

Depression is a major health problem associated with significant disability and economic costs. Although depression can be treated effectively with several psychological and pharmacological treatment options, many sufferers still seek or receive inadequate therapy or no therapy at all. Internet-based treatments may help to serve this demand, being accessible anytime and anywhere making it easier for underserved populations and people living in remote areas to receive treatment. The present study aims to assess the efficacy of an internet-based CBT intervention for depression (Deprexis), directly comparing the benefits of a low intensity therapist-guided with an unguided self-help version. A waiting-list control group will be included. Individuals meeting the diagnostic criteria of major depression or dysthymia will be randomly assigned to one of the three conditions. While unguided self-help will not include any contact with a therapist or the study team during the treatment, guided self-help will include a weekly scheduled e-mail feedback by a therapist and the possibility to ask questions via e-mail. While in an earlier study Deprexis was assessed as an add-on to TAU, this study will examine the efficacy of the program when delivered as a stand-alone intervention (i.e., only individuals who currently do not receive psychotherapy will be included). Moreover, this study will include a structured diagnostic interview at pretreatment. Only participants fulfilling the criteria of a depressive disorder (major depression or dysthymia) will be included in the trial. Participants will be recruited in Switzerland and Germany via articles in national and regional newspapers and a national television interview. All questionnaires will be administered via the internet. The 21-item BDI-II will be used as the main outcome measure. Secondary outcome measures will include the Brief Symptom Inventory (53-item BSI), the Inventory of Interpersonal Problems (64-item IIP), and the WHOQOL-BREF.

Interventions

DEVICEDeprexis

CBT-based, integrative online self-help program

Sponsors

University of Bern
CollaboratorOTHER
Linkoeping University
CollaboratorOTHER_GOV
Karolinska Institutet
CollaboratorOTHER
Gaia AG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* access to the internet * informed consent to participate * BDI-II score \> 13 * if prescribed, constant dosage of medication (depression/anxiety) for 1 month prior and during study

Exclusion criteria

* suicide item of BDI ≥ 2 * other psychological treatment during this study

Design outcomes

Primary

MeasureTime frameDescription
Beck Depression Inventory - II (BDI-II)10 weeksSelf-report questionnaire, depression symptom severity, scores can range from 0 to 63, with higher scores indicating more severe depression.

Secondary

MeasureTime frameDescription
Brief Symptom Inventory (53-item BSI)10 weeksPsychopathology severity self-report measure; minimum value = 0, maximum value = 4 (higher scores indicate more severe psychopathology).
Inventory of Interpersonal Problems (IIP)10 weeksSelf-report measure of interpersonal problems; total score computed as the mean across all items; minimum value = 0, maximum value = 4 (higher scores indicate more severe psychopathology)
WHOQOL-BREF10 weeksSelf-report quality of life measure; scores can range from 0 to 100, with higher scores indicating better quality of life.

Other

MeasureTime frameDescription
CSQ-8 (Client Satisfaction Questionnaire)10 weeksSelf-report measure of global client satisfaction; scores can range from 1 to 4, with higher scores indicating greater satisfaction.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026